Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET

Although SCARLET could not achieve its primary end‐point, the conditions of this trial were different from that of clinical practice in Japan. The effectiveness of the anticoagulant therapy for septic disseminated intravascular coagulation should be examined further in future studies.

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Tanaka, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328919/
https://www.ncbi.nlm.nih.gov/pubmed/30651991
http://dx.doi.org/10.1002/ams2.372
_version_ 1783386732529451008
author Iba, Toshiaki
Tanaka, Hiroshi
author_facet Iba, Toshiaki
Tanaka, Hiroshi
author_sort Iba, Toshiaki
collection PubMed
description Although SCARLET could not achieve its primary end‐point, the conditions of this trial were different from that of clinical practice in Japan. The effectiveness of the anticoagulant therapy for septic disseminated intravascular coagulation should be examined further in future studies.
format Online
Article
Text
id pubmed-6328919
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63289192019-01-16 Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET Iba, Toshiaki Tanaka, Hiroshi Acute Med Surg Editorial Although SCARLET could not achieve its primary end‐point, the conditions of this trial were different from that of clinical practice in Japan. The effectiveness of the anticoagulant therapy for septic disseminated intravascular coagulation should be examined further in future studies. John Wiley and Sons Inc. 2018-11-22 /pmc/articles/PMC6328919/ /pubmed/30651991 http://dx.doi.org/10.1002/ams2.372 Text en © 2018 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Editorial
Iba, Toshiaki
Tanaka, Hiroshi
Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title_full Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title_fullStr Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title_full_unstemmed Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title_short Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET
title_sort oh, how hard it is to open the gate for sepsis trials: lessons from scarlet
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328919/
https://www.ncbi.nlm.nih.gov/pubmed/30651991
http://dx.doi.org/10.1002/ams2.372
work_keys_str_mv AT ibatoshiaki ohhowharditistoopenthegateforsepsistrialslessonsfromscarlet
AT tanakahiroshi ohhowharditistoopenthegateforsepsistrialslessonsfromscarlet

Ejemplares similares